Singapore HSA registration DE0507604
Diasorin LIAISON Mumps IgG
Singapore·CLASS B IVD·DiaSorin Italia S.p.A.·Registered December 14, 2022Device classification
- Device Class
- CLASS B IVD
- Medical Speciality Area
- Immunology
Registration information
- Registration Number
- DE0507604
- Registration Date
- December 14, 2022
- Change Notification Approval Date
- January 16, 2023
- Retention Due Date
- December 13, 2025
Product description
The LIAISON® Mumps IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi- quantitative determination of specific IgG antibodies to mumps virus in human serum samples. It is intended to be used as an aid in the determination of serological status to mumps virus. The test has to be performed on the LIAISON® Analyzer family.
Product Owner
- Short Name
- DiaSorin Italia S.p.A.
- Address
- Via Crescentino, snc, 13040 Saluggia (VC) Italy, ITALY
Registrant
- Address
- 100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Importer
- Address
- 100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Model information
- Model Name(s)
- LIAISON Mumps IgG LIAISON Control Mumps IgG
- Model Identifier(s)
- 318840 318841
About this record
Access comprehensive regulatory information for Diasorin LIAISON Mumps IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507604 and owned by DiaSorin Italia S.p.A.. The device was registered on December 14, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD